Table 4.
Research code | Generic name | Sponsor | Status |
---|---|---|---|
UK-453,061 | Lersivirine | ViiV Healthcare | Phase IIb |
GSK 2248761 (formerly IDX 899) | – | ViiV Healthcare | Phase IIb |
RDEA806 | – | Ardea Bioscience | Phase IIa |
BILR 355 BS | – | Boehringer Ingelheim Pharmaceuticals | Phase IIa |
(+)-Calanolide A | – | Sarawak MediChem Pharmaceuticals | Phase I |
MK-4965 | – | Merck Research Laboratories | Phase I |
MK-6186 | – | Merck Research Laboratories | Phase I |
MK-1439 | – | Merck Research Laboratories | Phase I |